Boothbay Fund Management, LLC Merck & Co., Inc. Call Options Transaction History

Boothbay Fund Management, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	BUY	$87.44 - $112.11 $2.71 Million - $3.48 Million	31,000 Added 607.84%	36,100 $4 Million
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $10.3 Million - $11.6 Million	-122,000 Reduced 95.99%	5,100 $439,000
Q2 2022 Aug 15, 2022	BUY	$83.49 - $94.64 $9.75 Million - $11.1 Million	116,800 Added 1133.98%	127,100 $11.6 Million
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $42.3 Million - $47.4 Million	-575,500 Reduced 98.24%	10,300 $845,000
Q3 2021 Nov 15, 2021	BUY	$71.68 - $78.83 $42 Million - $46.2 Million	585,800 New	585,800 $44 Million

3,821

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $244B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.